July 18 (Reuters)—UnitedHealth Group Inc. will stick with its decision to pass on drug maker discounts to patients to help them beat rising medicine prices despite the U.S. government having withdrawn a similar proposed policy in its health programs, its top executive said on Thursday. “You can expect us not to change our stance on…